By presenting an ambiguous response, that is, a response that favors either advanced infection or induces the microbicidal activity of defense cells, Nrf2 may be the crucial target of future pharmacological interventions (Deramaudt et al., 2013; Shah et al., 2018; Cuadrado et al., 2019). Here, NFE2L2 is linked to infection.